RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research| diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology. RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases| applying rheumatology research to clinical practice| epidemiology of rheumatic diseases| diagnostic tests for rheumatic diseases| patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications| short communications| editorials| and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research| including in vitro or animal studies| is discouraged to submit| as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production. Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.
数据整理自公开网络的投稿反馈，仅供参考。
